Total Valuation
Appili Therapeutics Inc Class A has a market cap or net worth of $1.43M. The enterprise value is $15.17.
Market Cap$1.43M
Enterprise Value$15.17
Share Statistics
Appili Therapeutics Inc Class A has 132,366,120 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding132,366,120
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Appili Therapeutics Inc Class A’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 148.65%.
Return on Equity (ROE)0.24
Return on Assets (ROA)-2.15
Return on Invested Capital (ROIC)148.65%
Return on Capital Employed (ROCE)0.39
Revenue Per Employee34.88K
Profits Per Employee-605.82K
Employee Count7
Asset Turnover0.12
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Appili Therapeutics Inc Class A is ―. Appili Therapeutics Inc Class A’s PEG ratio is -0.00744.
PE Ratio―
PS Ratio7.60
PB Ratio-0.11
Price to Fair Value-0.11
Price to FCF-1.34
Price to Operating Cash Flow-1.47
PEG Ratio-0.00744
Income Statement
In the last 12 months, Appili Therapeutics Inc Class A had revenue of 244.18K and earned -4.24M in profits. Earnings per share was -0.03.
Revenue244.18K
Gross Profit236.09K
Operating Income-6.53M
Pretax Income-4.14M
Net Income-4.24M
EBITDA-6.53M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -1.35M and capital expenditures 36.98K, giving a free cash flow of -1.32M billion.
Operating Cash Flow-1.35M
Free Cash Flow-1.32M
Free Cash Flow per Share>-0.01
Dividends & Yields
Appili Therapeutics Inc Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.79
52-Week Price Change-26.67%
50-Day Moving Average0.01
200-Day Moving Average0.01
Relative Strength Index (RSI)45.98
Average Volume (3m)43.77K
Important Dates
Appili Therapeutics Inc Class A upcoming earnings date is Nov 12, 2026, After Close (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateNov 12, 2026
Ex-Dividend Date―
Financial Position
Appili Therapeutics Inc Class A as a current ratio of 0.11, with Debt / Equity ratio of -70.05%
Current Ratio0.11
Quick Ratio0.11
Debt to Market Cap6.97
Net Debt to EBITDA-1.98
Interest Coverage Ratio-6.45
Taxes
In the past 12 months, Appili Therapeutics Inc Class A has paid 96.85K in taxes.
Income Tax96.85K
Effective Tax Rate-0.02
Enterprise Valuation
Appili Therapeutics Inc Class A EV to EBITDA ratio is -2.26, with an EV/FCF ratio of -10.66.
EV to Sales60.41
EV to EBITDA-2.26
EV to Free Cash Flow-10.66
EV to Operating Cash Flow-10.66
Balance Sheet
Appili Therapeutics Inc Class A has $138.68K in cash and marketable securities with $13.33M in debt, giving a net cash position of -$13.19M billion.
Cash & Marketable Securities$138.68K
Total Debt$13.33M
Net Cash-$13.19M
Net Cash Per Share-$0.10
Tangible Book Value Per Share-$0.14
Margins
Gross margin is 98.46%, with operating margin of -2675.64%, and net profit margin of -1736.73%.
Gross Margin98.46%
Operating Margin-2675.64%
Pretax Margin-1697.07%
Net Profit Margin-1736.73%
EBITDA Margin-2672.33%
EBIT Margin-2675.64%
Analyst Forecast
The average price target for Appili Therapeutics Inc Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast252.01%
EPS Growth Forecast-91.97%